封面
市场调查报告书
商品编码
1947087

2026年机器人辅助经皮冠状动脉介入治疗(PCI)全球市场报告

Robot-Assisted Percutaneous Coronary Intervention (PCI) Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,机器人经皮经皮冠状动脉介入治疗(PCI)市场发展迅速,预计将从2025年的275.6亿美元成长到2026年的387.3亿美元,复合年增长率达40.5%。过去几年的增长被认为归因于多种因素,例如冠状动脉疾病患病率的上升、手动PCI的精确性局限性、导管介入治疗的日益普及、人们对辐射风险的认识不断提高以及心臟导管检查室的扩建。

预计未来几年,机器人经皮经皮冠状动脉介入治疗(PCI)市场将呈指数级增长,到2030年市场规模将达到1,496.8亿美元,复合年增长率(CAGR)为40.2%。预测期内的成长要素包括机器人介入技术的进步、心臟病学领域自动化程度的提高、数位医疗基础设施投资的增加、对复杂高风险PCI手术需求的成长,以及监管机构对机器人系统核准的支持。预测期内的主要趋势包括微创心血管手术的普及、对减少临床医生辐射暴露的日益重视、对手术精准度和准确性的需求不断增长、复杂冠状动脉介入治疗能力的提升,以及患者安全性和临床疗效的改善。

心血管疾病盛行率的上升预计将推动机器人辅助经皮冠状动脉介入治疗(PCI)市场的成长。心血管疾病是指影响心臟和血管的一系列疾病,包括冠状动脉疾病、心肌梗塞和中风。这些疾病发生率的上升主要是由于肥胖、高血压和久坐不动的生活方式导致心血管健康状况不佳。机器人辅助PCI透过精准地重新开通阻塞或狭窄的冠状动脉,恢復心臟血流,进而治疗心血管疾病。同时,它还能最大限度地降低手术风险和辐射暴露,改善患者预后。例如,根据英国政府机构GOV.UK于2024年12月发布的数据,截至2024年3月,英格兰约有224万成年人(约占18岁及以上人口的4.4%)被全科医生诊断患有慢性肾臟病(CKD),高于前一年的209万人。因此,心血管疾病的日益普遍正在推动机器人辅助经皮冠状动脉介入治疗(PCI)市场的成长。

机器人经皮经皮冠状动脉介入治疗 (PCI) 市场的主要企业正在投资先进的机器人心臟病学平台,以提高患者安全性并简化复杂的冠状动脉手术。机器人心臟病学平台是先进的系统,可辅助心臟科医师进行精准可控的冠状动脉介入治疗,从而提高手术准确率,减少人为错误,并降低患者和医务人员的辐射暴露。例如,2023 年 5 月,专注于机器人血管介入解决方案的法国公司 Robocath SAS 发布了 R-One+。这款尖端机器人系统使介入性心臟病专家能够透过导管检查室或控制室内的整合控制单元操作设备并执行 PCI 手术。 R-One+ 可提高设备操作精度,降低患者和医务人员的辐射曝射量,并为操作人员提供更舒适的工作环境。在巴黎举行的 EuroPCR 会议上,RoboCas 重点介绍了其新功能,这些功能使 PCI 手术更安全、更有效率,同时保护心臟病团队免受辐射相关伤害。此次发布再次印证了 Robocath SAS 致力于透过智慧机器人辅助技术推动心血管疾病治疗进步的承诺。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场:吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧(AI)和自主人工智慧
    • 自主系统、机器人与智慧运输
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 微创心血管手术的普及率不断提高
    • 人们越来越关注减少医护人员的辐射暴露。
    • 对精度和程序准确性的需求日益增长
    • 拓展复杂冠状动脉介入治疗能力
    • 提高病人安全性和临床疗效

第五章 终端用户产业市场分析

  • 医院
  • 心臟导管检查室
  • 门诊手术中心
  • 专科心臟诊所
  • 学术研究机构

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场规模、对比及成长率分析
  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场表现:规模与成长,2020-2025年
  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场预测:规模与成长,2025-2030年,2035年预测

第八章 全球潜在市场规模(TAM)

第九章 市场细分

  • 按组件
  • 机器人系统、导管和导管导引线、主机
  • 透过使用
  • 冠状动脉成形术、支架置入术、血栓切除术
  • 最终用户
  • 医院、心臟导管检查室、门诊手术中心和其他终端用户
  • 按类型细分:机器人系统
  • 电子机械机械臂、影像整合单元、机器人驱动系统
  • 按类型细分:导管和导管导引线
  • 冠状动脉导管导引线、球囊导管、药物释放型导管
  • 按类型细分:主机
  • 触控萤幕介面、操纵桿控制器、影像显示面板

第十章 区域与国家分析

  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场:区域分析、预测(2020-2025年、2025-2030年预测、2035年预测)
  • 全球机器人经皮经皮冠状动脉介入治疗(PCI)市场:国家、绩效及预测,2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章:中国市场

第十三章 印度市场

第十四章 日本市场

第十五章:澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章:西欧市场

第21章英国市场

第22章 德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章 东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第30章:加拿大市场

第31章 南美洲市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第35章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 机器人经皮经皮冠状动脉介入治疗(PCI)市场:竞争格局与市场份额,2024年
  • 机器人经皮经皮冠状动脉介入治疗(PCI)市场:公司估值矩阵
  • 机器人经皮经皮冠状动脉介入治疗(PCI)市场:公司概况
    • Medtronic plc
    • Siemens Healthineers AG
    • Boston Scientific Corporation
    • Intuitive Surgical
    • BIOTRONIK SE & Co. KG

第37章:其他领先和创新企业

  • MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc.

第38章:全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年机器人经皮经皮冠状动脉介入治疗(PCI)市场:提供新机会的国家
  • 2030年机器人经皮经皮冠状动脉介入治疗(PCI)市场:充满新机会的市场区隔
  • 2030年机器人辅助经皮冠状动脉介入治疗(PCI)市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MRAPC01_G26Q1

Robot-assisted percutaneous coronary intervention (R-PCI) is a minimally invasive procedure in which robotic systems help navigate catheters, balloons, and stents to treat narrowed or blocked coronary arteries. This technology enhances precision, stability, and control, reducing human error while also minimizing radiation exposure for both patients and healthcare staff. The approach aims to improve procedural safety, efficiency, and overall clinical outcomes.

The primary components of robot-assisted PCI include robotic systems, catheters and guidewires, and control consoles. Robotic systems are advanced machines that enable physicians to remotely manipulate guidewires, balloons, and stents from a protected workstation. R-PCI is utilized in procedures such as coronary angioplasty, stent placement, and thrombectomy, and serves end users including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and other healthcare facilities.

Tariffs are impacting the robot-assisted pci market by increasing costs of imported robotic components, imaging units, and precision electromechanical systems. Robotic systems and control console segments are most affected, particularly in regions such as north america and asia-pacific that rely on global supply chains for advanced medical robotics. These cost pressures have slowed procurement for some hospitals. However, tariffs have also encouraged local manufacturing, strategic sourcing, and technology partnerships, supporting long-term innovation and regional production capabilities.

The robot-assisted percutaneous coronary intervention (pci) market research report is one of a series of new reports from The Business Research Company that provides robot-assisted percutaneous coronary intervention (pci) market statistics, including robot-assisted percutaneous coronary intervention (pci) industry global market size, regional shares, competitors with a robot-assisted percutaneous coronary intervention (pci) market share, detailed robot-assisted percutaneous coronary intervention (pci) market segments, market trends and opportunities, and any further data you may need to thrive in the robot-assisted percutaneous coronary intervention (pci) industry. This robot-assisted percutaneous coronary intervention (pci) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robot-assisted percutaneous coronary intervention (pci) market size has grown exponentially in recent years. It will grow from $27.56 billion in 2025 to $38.73 billion in 2026 at a compound annual growth rate (CAGR) of 40.5%. The growth in the historic period can be attributed to growth in coronary artery disease prevalence, limitations of manual pci precision, increasing use of catheter-based interventions, rising awareness of radiation risks, expansion of cardiac catheterization labs.

The robot-assisted percutaneous coronary intervention (pci) market size is expected to see exponential growth in the next few years. It will grow to $149.68 billion in 2030 at a compound annual growth rate (CAGR) of 40.2%. The growth in the forecast period can be attributed to advancements in robotic-assisted intervention technologies, increasing adoption of automation in cardiology, rising investment in digital healthcare infrastructure, growing demand for complex and high-risk pci procedures, supportive regulatory approvals for robotic systems. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, growing focus on reducing radiation exposure for clinicians, increasing demand for precision and procedural accuracy, expansion of complex coronary intervention capabilities, improved patient safety and clinical outcomes.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the robot-assisted percutaneous coronary intervention (PCI) market going forward. Cardiovascular diseases encompass disorders affecting the heart and blood vessels, including coronary artery disease, heart attacks, and stroke. The increase in these conditions is largely attributed to sedentary lifestyles, which contribute to obesity, hypertension, and poor cardiovascular health. Robot-assisted PCI addresses cardiovascular diseases by precisely reopening blocked or narrowed coronary arteries to restore blood flow to the heart, while minimizing procedural risks and radiation exposure, thereby improving patient outcomes. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England-approximately 4.4% of those aged 18 and over-had a GP-recorded diagnosis of CKD, up from 2.09 million cases the previous year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the robot-assisted PCI market.

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are investing in advanced robotic cardiology platforms to enhance patient safety and simplify complex coronary procedures. A robotic cardiology platform is a sophisticated system that assists cardiologists in performing precise and controlled coronary interventions while improving accuracy, reducing human error, and minimizing radiation exposure for both patients and medical personnel. For instance, in May 2023, Robocath SAS, a France-based firm specializing in robotic vascular intervention solutions, launched the R-One+. This cutting-edge robotic system allows interventional cardiologists to perform coronary angioplasties (PCI) by operating devices via an integrated command unit in the catheterization lab or control room. The R-One+ boosts precision in device handling, enhances safety for patients and staff by lowering radiation exposure, and provides more comfortable working conditions for operators. Its unveiling at the EuroPCR conference in Paris highlighted new capabilities that make PCI procedures safer and more efficient while protecting the cardiology team from radiation-related injuries. This launch underscores Robocath's dedication to advancing cardiovascular disease treatment through intelligent robotic assistance.

In April 2024, Microbot Medical, a US-based developer of robotic endovascular systems and minimally invasive vascular solutions, entered into a partnership with Corewell Health. Through this collaboration, Microbot Medical and Corewell Health aim to advance remote telesurgery by leveraging Microbot's LIBERTY Endovascular Robotic Surgical System. Corewell Health, a US-based healthcare provider, specializes in robotic-assisted procedures and focuses on enhancing patient care in cardiovascular interventions.

Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the robot-assisted percutaneous coronary intervention (pci) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The robot-assisted percutaneous coronary intervention (PCI) market consists of revenues earned by entities by providing services such as robotic catheter navigation, remote-controlled stent placement, real-time imaging integration, and procedural planning support. The market value includes the value of related goods sold by the service provider or included within the service offering. The robot-assisted percutaneous coronary intervention (PCI) market also includes sales of radiation shielding accessories, robotic arm components, monitoring and display units, integration interfaces, and sterile disposable kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses robot-assisted percutaneous coronary intervention (pci) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for robot-assisted percutaneous coronary intervention (pci) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robot-assisted percutaneous coronary intervention (pci) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Robotic Systems; Catheters And Guidewires; Control Consoles
  • 2) By Application: Coronary Angioplasty; Stent Placement; Thrombectomy
  • 3) By End-User: Hospitals; Cardiac Catheterization Laboratories; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Robotic Systems: Electromechanical Robotic Arms; Imaging Integration Units; Robotic Drive Systems
  • 2) By Catheters And Guidewires: Coronary Guidewires; Balloon Catheters; Drug-Eluting Catheters
  • 3) By Control Consoles: Touchscreen Interfaces; Joystick Controllers; Imaging Display Panels
  • Companies Mentioned: Medtronic plc; Siemens Healthineers AG; Boston Scientific Corporation; Intuitive Surgical; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Biosensors International Group Ltd.; OrbusNeich Medical Group Holdings Limited; Stereotaxis Inc.; Perfint Healthcare; Robocath Inc.; Meril Life Sciences Pvt. Ltd.; Abbott Laboratories; Philips Healthcare; Terumo Corporation; Asahi Intecc; Catheter Precision; Cardiobot; Remedics; meerecompany Inc.; AngioDynamics; Clear Surgical Inc.; GE Healthcare; Canon Medical Systems; Asensus Surgical; Endovascular Robotics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Minimally Invasive Cardiac Procedures
    • 4.2.2 Growing Focus On Reducing Radiation Exposure For Clinicians
    • 4.2.3 Increasing Demand For Precision And Procedural Accuracy
    • 4.2.4 Expansion Of Complex Coronary Intervention Capabilities
    • 4.2.5 Improved Patient Safety And Clinical Outcomes

5. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiac Catheterization Laboratories
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Cardiology Clinics
  • 5.5 Academic And Research Institutes

6. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Segmentation

  • 9.1. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Robotic Systems, Catheters And Guidewires, Control Consoles
  • 9.2. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Angioplasty, Stent Placement, Thrombectomy
  • 9.3. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users
  • 9.4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Sub-Segmentation Of Robotic Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems
  • 9.5. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Sub-Segmentation Of Catheters And Guidewires, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters
  • 9.6. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Sub-Segmentation Of Control Consoles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels

10. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Regional And Country Analysis

  • 10.1. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 11.1. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 12.1. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 13.1. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 14.1. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 15.1. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 16.1. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 17.1. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 18.1. Taiwan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 19.1. South East Asia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 20.1. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 21.1. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 22.1. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 23.1. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 24.1. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 25.1. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 26.1. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 27.1. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 28.1. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 29.1. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 30.1. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 31.1. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 32.1. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 33.1. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 34.1. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Regulatory and Investment Landscape

36. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Landscape And Company Profiles

  • 36.1. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Intuitive Surgical Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. BIOTRONIK SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis

37. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Other Major And Innovative Companies

  • MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc.

38. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

40. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market High Potential Countries, Segments and Strategies

  • 40.1 Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer